Press release
Nuclear Medicine Diagnostics market Trends, Segment and Future Growth to 2023 - Major Key growth factors
Nuclear Medicine Diagnostics market Overview
Nuclear medicine is a branch of medicine that used for radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, exact diagnosis of the patient's illness.
Over 10,000 hospitals in worldwide practice radioisotopes in medicine, and about 90% of these procedures are for diagnosis. The most general radioisotope accustomed in diagnosis is technetium-99, with some 40-45 million procedures per year (around 16.7 million in USA, 550,000 in Australia), aggregating to 80% of all nuclear medicine processes worldwide.
Request for Sample @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market-123/request-sample
Major driving factors for the growth of the current market are:
Rising demand for SPECT and PET analysis in radiopharmaceuticals
Expansion of better instruments
Newer computer-based proceses for image analysis and display
New 99mTc labeled agents for the visualizing biologically significant events
Rising use in clinical applications to study psychiatric disorders
Integration of X-Ray tomography (CT) into SPECT
Restraints
Some of the major constraints for the current market are:
Shorter half-life of the radioisotopes
Regular in guidelines
Reimbursement issues
High capital investment
Nuclear Medicine Diagnostics market Forecast Report (2018-2023)
The global Nuclear Medicine Diagnostic Market worth was $12.6 billion in 2018 and is expected to reach $23.42 billion by 2023, at a compound annual growth rate (CAGR) of 13.2%.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market-123/
Nuclear Medicine Diagnostics market Segmentation
The Nuclear Medicine diagnostic Market is divided into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application, the market is divided into SPECT (lymphoma, cardiology, neurology, thyroid and others) and PET (cardiology, oncology, neurology and others).
Furthermore, on the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. North America accounts for the large share of the nuclear medicine market, followed by Asia-Pacific and Europe.
Customize Report @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market-123/customize-report
Key Developments in the Market
In August 2016, the Eckert & Ziegler Group obtained BR - 77 Comércio, Distribuidora e Transportes de Medicamentos Ltd based in Brazil. Through this acquisition, the company targets to expand its presence in South America.
In 2018, The Curium signed an agreement to acquire Cyclopharma’s manufacturing and commercial operations in France.
In 2018, AAA received US FDA Approval for the LUTATHERA used in the treatment of gastro enteropancreatic neuroendocrine tumors.
Major Players:
Some of the major players in this market are
Cardinal Health (US)
GE Healthcare (US)
Curium (France)
Bayer (Germany)
Lantheus Medical Imaging (US)
Advanced Accelerator Applications (France)
Jubilant Life Sciences (India)
Buy now @ https://www.marketdataforecast.com/cart/buy-now/nuclear-medicine-diagnostics-market-123/
About Us
Market Data Forecast is determined working in the areas of market research, business intelligence and consulting. We have a great experience in research and consulting for various business domains to cater the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com
Nuclear medicine is a branch of medicine that used for radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, exact diagnosis of the patient's illness.
Over 10,000 hospitals in worldwide practice radioisotopes in medicine, and about 90% of these procedures are for diagnosis. The most general radioisotope accustomed in diagnosis is technetium-99, with some 40-45 million procedures per year (around 16.7 million in USA, 550,000 in Australia), aggregating to 80% of all nuclear medicine processes worldwide.
Request for Sample @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market-123/request-sample
Major driving factors for the growth of the current market are:
Rising demand for SPECT and PET analysis in radiopharmaceuticals
Expansion of better instruments
Newer computer-based proceses for image analysis and display
New 99mTc labeled agents for the visualizing biologically significant events
Rising use in clinical applications to study psychiatric disorders
Integration of X-Ray tomography (CT) into SPECT
Restraints
Some of the major constraints for the current market are:
Shorter half-life of the radioisotopes
Regular in guidelines
Reimbursement issues
High capital investment
Nuclear Medicine Diagnostics market Forecast Report (2018-2023)
The global Nuclear Medicine Diagnostic Market worth was $12.6 billion in 2018 and is expected to reach $23.42 billion by 2023, at a compound annual growth rate (CAGR) of 13.2%.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market-123/
Nuclear Medicine Diagnostics market Segmentation
The Nuclear Medicine diagnostic Market is divided into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application, the market is divided into SPECT (lymphoma, cardiology, neurology, thyroid and others) and PET (cardiology, oncology, neurology and others).
Furthermore, on the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. North America accounts for the large share of the nuclear medicine market, followed by Asia-Pacific and Europe.
Customize Report @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market-123/customize-report
Key Developments in the Market
In August 2016, the Eckert & Ziegler Group obtained BR - 77 Comércio, Distribuidora e Transportes de Medicamentos Ltd based in Brazil. Through this acquisition, the company targets to expand its presence in South America.
In 2018, The Curium signed an agreement to acquire Cyclopharma’s manufacturing and commercial operations in France.
In 2018, AAA received US FDA Approval for the LUTATHERA used in the treatment of gastro enteropancreatic neuroendocrine tumors.
Major Players:
Some of the major players in this market are
Cardinal Health (US)
GE Healthcare (US)
Curium (France)
Bayer (Germany)
Lantheus Medical Imaging (US)
Advanced Accelerator Applications (France)
Jubilant Life Sciences (India)
Buy now @ https://www.marketdataforecast.com/cart/buy-now/nuclear-medicine-diagnostics-market-123/
About Us
Market Data Forecast is determined working in the areas of market research, business intelligence and consulting. We have a great experience in research and consulting for various business domains to cater the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
